CASP3 and ovarian carcinoma: However, silencing GOLPH3L via GOLPH3L -shRNA enhance the cytotoxic effect of CDDP on ovarian cancer cells, which resulted in remission tumor progression and increased TUNEL+-cells, active caspase 3 cells compared with that in the control group (Fig. 3d-f).